chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ED to Hosp-Admission Discharged  3/28/2021 - 4/2/2021 (5 days) Treatment team. Acute hypoxemic respiratory failure due to COVID-19 Principal problem Discharge Summary (Physician) Internal Medicine           Discharge Summary   Hospitalist Medicine        Admission Date: 3/28/2021 PCP: (doctor) Length of Stay: 5 Days Discharging provider: (doctor) Discharge Date: 4/2/2021     Admission Diagnosis     Hospital Problems          POA   * (Principal) Acute hypoxemic respiratory failure due to COVID-19  Yes       Cardiomyopathy  Yes       Obstructive sleep apnea syndrome Yes       Essential hypertension Yes       Type 2 diabetes mellitus  Yes       Presence of automatic (implantable) cardiac defibrillator Unknown       Pneumonia due to 2019 novel coronavirus Yes       Stage 4 chronic kidney disease  Yes       Pneumonia of both lungs due to infectious organism, unspecified part of lung Yes       Atrial fibrillation with rapid ventricular response  Yes       NSTEMI (non-ST elevated myocardial infarction)  Yes       Hospital Course:      Patient is a pleasant 79-year-old male admitted due to acute hypoxic respiratory secondary COVID-19 pneumonia. He was continued on dexamethasone for the COVID-19 pneumonia however the medicine was relatively contraindicated due to renal failure. Patient was seen by cardiology continued on aspirin beta-blocker and statin for non-STEMI and already was anticoagulated with Xarelto which is continued. Patient's oxygenation requirements did improve and he was set up for home oxygen prior to discharge. Patient was continue with PT and OT and slowly did well he was doing well clinically at this time may be discharged home for convalescence as per protocol. Patient may follow-up with PCP and specialist as noted
This spontaneous report was received from a physician's assistant refers to a 14 year old female patient. No concurrent condition or medical history was reported. On 15-JUN-2012, the patient was vaccinated with first dose of VAQTA. On 18-NOV-2015 the patient was vaccinated with second dose of expired VAQTA (lot # K008254, exp. 12-NOV-2015) (25/0.5, intramuscularly) (Incorrect product storage). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. Additional information has been requested.
The patient was here to receive the Pfizer bivalent vaccine but was given the regular Pfizer vaccine.
Arm pain at site lasting more than 24 hours. Radiating arm and neck pain and stiffness for first day, eased with sleep overnight. Feverish and chills in the evening of first night, eased with sleep overnight.
Pfizer monovalent vaccine ordered by provider and administered by nursing staff. After dose was administered, patient provided documentation that she had previously received 2 doses of Pfizer monovalent vaccines, one in 6/2022 and another 7/2022
Big red circle on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Big red circle on injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2022, the patient experienced VACCINATION SITE ERYTHEMA (Big red circle on injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Big red circle on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
headache, lethargy, dizziness, low grade fever, feeling not well, nausea, chills, body aches
Narrative:  Patient presented from home to ED on 09/07/2022 with chief complaint of increased dyspnea and tachycardia. Tested positive for COVID on 09/01/2022. Treated with acetylcysteine 3mL neb Q8hrs, dexamethasone 6mg IV daily, and remdesivir 100mg daily.
pt started itching 1 hr p/inject; later that eve noticed rash on face & chest; itching lasted for 3-4 days; rash lasted x 1wk; some raised bumps w/rash;
some SVT episodes; I wore a heart monitor; PVC; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FC3181), via an unspecified route of administration, in left arm on 23Aug2021 16:00 (at the age of 34-years-old) as dose 2, single for COVID-19 immunization. Medical history included supraventricular Tachycardia (SVT) in 2004 and catheter ablation was performed, covid-19 prior to vaccination. Concomitant medication included valacyclovir, fish oil and OLLY Women's Multi. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number:EV00181), via an unspecified route of administration, in left arm on 02Aug2021 15:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization after which the patient experienced few heart flutter episodes and shortness of breath. The patient reported that he wore a heart monitor and had some SVT episodes and PVC was noted on the reports a week after second dose in Aug2021. The patient underwent lab tests and procedures which included investigation: PVC was noted on 02Aug2021, sars-cov-2 test: negative on 02Sep2021 Nasal Swab, sars-cov-2 test: negative on 07Sep2021 Nasal Swab. The events resulted in physician office visit. The patient did not receive any treatment for the events. The outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Client got vaccinated with JJ at facility who previously got 2 Moderna before at pharmacy.  Vaccine Record: 1st Moderna: 06/07/2021  Lot #049C21A 2nd Moderna: 07/09/2021 Lot #052C21A Janssen: 09/07/2021 Lot #201A21A  We found out that she got the vaccine when her sister came over to tell she's vaccinated already. We checked in system during registration. She used a different name in pharmacy that's why her record did not show . She didnt know that the vaccine she got from pharmacy was COVID vaccine.
Customer experienced numbness that started about a half-hour when she arrived home. Then 5-6 days later, she felt an enlarged lymph node by left axillary and pain in that area. She felt more painful at night. Also, if she ate spicy food, more numbness. When she stopped, numbness left (or numbness lessened). She missed her period for 1 month. She was suppose to get her period around her vaccine day, but she still did not receive her period. She thought she was pregnant, and checked with her doctor's office. Not pregnant.
Got covid after being vaccinated; Got covid after being vaccinated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Mar2021 as dose 1, single (Lot number: EN6207), in left arm, on 06Apr2021 as dose 2, single (Lot number: EWO151), in left arm and on 19Dec2021 as dose 3 (booster), single (Lot number: 3313OBA) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ADVIL [IBUPROFEN], start date: 27May2022, stop date: 01Jun2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 28May2022, outcome "unknown" and all described as "Got covid after being vaccinated". Therapeutic measures were taken as a result of vaccination failure, covid-19 with PAXLOVID (Start date: 28May2022, stop date: 01Jun2022, lot number=GC0529).   Clinical course: Patient got Covid after being vaccinated and PAXLOVID caused a very bitter taste in patient's mouth the whole time she took it.  Follow-up attempts are completed. No further information is expected.
Diagnosis: Nephrotic syndrome, no underline health conditions.  Signs/ symptoms Fluid retention, proteinuria, weight gain, low albumin and high triglycerides. Treatment: kidney biopsy, lisinopril, famotidine, prednisone, sulfa antibiotics, diuretic. Treatment is currently still on going with monthly labs as I tapper off prednisone.
Headache, Arthralgia, Fatigue, hills, injection site pain and swelling Narrative:
I began losing my voice with the 1st shot on 7/26/2021, Pfizer Lot FA7484; with the second shot it worsened, 8/20/2021, given at store pharmacy, Pfizer FC 3181, after the booster, my voice was essentially gone.  My voice has not returned since that time.
pt recvd vax & 22DEC93 flu-like illness, 1JAN94 icteric; hospitalized 6JAN94 dx Hep A; HBsAg=neg; HBSAb-pos; HBcAg=neg; HAAb=pos; HAAb IgM=pos; HAcAb neg; weakness & numbness legs over fev dasy dx GBS;
TEMPERATURE EXCURSION OCCURRED DUE TO THE PLACEMENT OF HAND WARMERS IN THE INSULATED BAG USED TO TRANSPORT VACCINE. ALL 81 PERSONS RECEIVING VACCINE IN LANES 5 AND 6 AT THE ON 02/15/2021 BETWEEN 14:00 and 16:45 WERE NOTIFIED THEY  RECEIVED VACCINE THAT WAS OUTSIDE OF THE APPROPRIATE TEMPERATURE RANGE AND WERE RECOMMENDED TO BE REVACCINATED.
Severe body aches, weird taste in mouth, chest tightness, difficulty breathing, fever, chills, the next day I think I hallucinated during the fever and extreme body aches. Most symptoms lasted 24 hours but the rest of them continued.
Low grade fever; chills; nausea; fatigue; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) in the left arm at 23Mar2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included ulcerative colitis (reported UC). The patient's concomitant medications taken in two weeks included vitamin B12 (MANUFACTURER UNKNOWN) and mesalamine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) at 10:00 (at the age of 51-years-old) in the left arm on 01Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 22:00, the patient experienced low grade fever, chills, nausea, fatigue and sore arm. Therapeutic measures were not given as a result of fever, chills, nausea, fatigue and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, nausea, fatigue and sore arm was resolved on an unknown date.   No follow-up attempts are needed. No further information is expected.
Pain in right leg knee; Pain in hip; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 12:00 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported but unspecified. The patient had no allergies to medications, food, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included carbidopa, levodopa (MANUFACTURER UNKNOWN) from an unknown date, for unknown indication. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 9264) via an unspecified route of administration in the left arm on 08Feb2021 at 12:00 (at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine.  On 01Mar2021 at 23:00 the patient experienced pain in right leg knee and pain in hip. Therapeutic measures were taken as a result of pain in right leg knee and pain in hip and included treatment with physical therapy and MRI.  Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in right leg knee and pain in hip were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
starting on the day immun was given pt devel a high fever & irritability, fever, irritability w/crying lasted for 3 days; temp was not taken by parent nor was pt seen by MD;
I received my vaccine on 07/06/2022. That night, I work up and my arm was asleep and it was difficult to move.  On 07/08/2022, I had a severe headache and sore throat.  My head is throbbing and I am being treated like it's a migraine.  I have had a  Toradol shot for the pain. I've been to ER where they gave me a cocktail of stuff for the pain. I have been taking  Imitrex, Naproxen and Norco .  I have had COVID-19 twice: 01/08/2022 and  04/2021.
A non-serious spontaneous report of inadvertent administration of expired H1N1 and patient was given 2nd dose was received from a registered nurse/health professional concerning a ten-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Within 20 min I had a tingling tongue, burning tongue and back of throat that increased in intensity > this continued for 17 hrs. I took kids liquid Benadryl (because pill form has same preservatives as vaccine!) at adult dose. 3:00am my face and eyes were puffy. I could breath okay. This all went away by late morning or so the following day. I've also had a noticeable increase in my tinnitus. I was told April 22 when I went to receive my 2nd dose, that I could not have it unless I do it in a hospital and be prepared for dealing with a more intense allergic reaction. I have not received it and probably won't.
pt recv vax 7AUG97 & awoke 8AUG97 (AM) w/pain, swelling & redness of rt knee & thigh distal to inj site;APAP given, ice applied & legs elevated;examined in clinic 11AUG97 & rt thigh measured 9 1/2 above knee cap lt thigh 9";DPH given;
low grade fever which climbed to 105 @ 330AM;fever responds to APAP/Motrin;fussy some redness @ inj site;
Employee developed an Urticarial rash involving, right side of abdomen, extending to the right flank. both upper arms, and posterior knees, and thighs.
Pain, stiffness, and weakness began in left hip.  Arms were weak also.  Eventually moved to both hips, groins, arms, hands, neck, jaw, collar-bone area.  Was almost totally incapacitated -- couldn't get up from chair, toilet, or bed, couldn't sleep in bed because of pain, needed help getting dressed, couldn't go up and down stairs, couldn't drive, couldn't do normal household chores, extreme fatigue. Doctor ordered lab work and determined I had Polymyalgia Rheumatica -- which I never had before.  Never had any rheumatic disease.  She prescribed 15 mg daily Predisone and Hydrocodone.  Within two days, symptoms eased considerably.  After taking for two weeks, much improvement so she had me cut Predisone to 10 mg; however, symptoms began coming back.  So back on 15 mgs. again.  Now, two weeks later, symptoms are basically gone.  Talked to doctor again today.  She is having me cut back on Prednisone more slowly -- only 1 mg at a time over a longer period.  My left hip started bothering me approximately on March 1, 2021.  By the first part of May, it had spread to all the parts of my body listed above.  I contacted doctor approximately on 6/1/2021 and started taking Predisone.  I talked to her again 6/11/2021 and 7/15/2021.
Stated to become more noticeable on day 3 of vaccine then today 4 red area larger than baseball size and warm to touch and now going around arm. Treatment, cold compress and BENADRYL.
Patient experienced erythema > 100mm along the left arm which was warm to the touch. Erythema first appeared approximately 16 hours after receiving vaccinations, with pain at injection site still present 2 days later, but improving from previous day
Inappropriate schedule of vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 26-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was provided.  No treatment information provided.   This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, (Batch number: unknown) with no associated AEs.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, (Batch number: unknown) with no associated AEs.
Per Regulatory Authority guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
2/12/23 I had done something to my left shoulder and unsure what it is. I am having shoulder pain and weakness. I went to the doctor and had an x-ray, which was normal, and had a steroid injection into the bursa area of my shoulder which did not help. I have an MRI scheduled.
Information has been received from a registered nurse concerning a 6 year old male who on 05/07/1999, at the age of 12 months, was vaccinated in the left arm with the first dose of varicella virus vaccine live.  The RN reported that on 02/24/2005, the patient developed mild breakthrough characterized by less than 50 lesions.  It was unknown if medical attention was sought.  At the time of this report, the patient noted to be recovering from the breakthrough.  Additional information has been requested.this is in follow-up to report (s) previously submitted on 5/16/2005. Information has been received from a physician and a registered nurse concerning a 6-year-old male who on 07-MAY-1999, at the age of 12 months, was vaccinated in the left arm with the first dose of VARIVAX (Merck) (Lot #628182/1327H). concomitant vaccinations on that same day included the first dose in the right arm of MMR II (Lot #610104/0127J). It was reported that on 24-FEB-2005, the patient developed a very mild case of breakthrough varicella characterized by less that 50 lesions. It was unknown if medical attention was sought. At the time of this report, the patient was noted to be recovering well from the breakthrough varicella. No further information is available.
This spontaneous report concerning a 17 year old female patient was received from the patient's mother. Information on patient's concurrent conditions and medical pertinent history was not provided; however she was allergic to MOTRIN and AUGMENTIN. On an unknown date, the patient was vaccinated with a 1st dose of GARDASIL intramuscularly, (anatomical location, dose, lot # and expiration date not provided). On 29-SEP-2014, the patient was vaccinated with a second dose of GARDASIL. Subsequently, on the same date, the patient started fainted and started to have seizures, also reported as "seizure like spells". The patient sought medical attention and was seeing by a neurologist and a cardiologist; she received MIDRON as treatment and performed an electrocardiogram and a computed tomography scans (results not provided). On 25-NOV-2015, the patient received the third dose of GARDASIL 9. No product quality complaint was involved. The outcome of the events was unknown. No product quality complaint was involved. The relatedness between the vaccination with GARDASIL seizures and syncope was not reported. Upon internal review the event of seizures was considered as medically significant. Additional information has been requested.
48hr p/vax diarrhea, lasted 6 days;72hr p/vax fever of 105 treated w/Ibuprofen alternating w/APAP;fever lasted 3 days, kept rising to 104;
This two year old patient with no medical history experienced fever of 103 F approximately 12 hours post nasal vacinnation. The fever lasted 5 days and varied between 101 and 104 F. Was seen at urgent care on 11/Oct/2009 and it was determined that it was a H1N1 vaccine adverse reaction. Treatment including alternating tylenol and motrin every four hours until the fever went away. Other non significant symptoms included fatigue and lack of interest in playing with toys.
After receiving Bexsero vaccine and finger stick, patient fainted/lost consciousness from sitting position on exam table and fell to the floor hitting the back of her head. Event was witnessed by nurse who said patient lost consciousness for 30-60 seconds, no seizure-like activity was witnessed. Nurse was walking out of the room when the patient fell off the exam table. When asked exactly what transpired, she explained that vaccine and labs were drawn without issue, patient verbalized that she was feeling fine and stayed in sitting position, nurse turned around to walk out of the room/back was to the patient and just as she was exiting the room patient slipped off the table (she believes the LOC occurred before making contact with the ground), height of the table from ground was ~30 inches.
18 HOURS  AFTER INJECTION: SLIGHT SWELLING AT BICEP , APPROXIMATELY TWO INCHES BELOW INJECTION SITE.   ITCHING. 28 HOURS AFTER INJECTION: FEVER OF 102. BROKE AFTER 8 HOURS. 36 HOURS AFTER INJECTION:  REDNESS PATCH ON BICEP APPROXIMATELY 3" X 3", CONTINUED ITCHING AND SENSITIVITY. 106 HOURS AFTER INJECTION FEELING WELL, SENSITIVITY, ITCHING AND SLIGHT REDNESS CONTINUES.
Eyes rolled back, arms and legs stiffened out and began shaking for 5-6 seconds.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypotension-Mild, Additional Details: pt experienced lightheadedness and blurry vision x 10 min after covid inj which resolved without any intervention